Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 214596
Company: CIPLA
Company: CIPLA
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
PHYTONADIONE | PHYTONADIONE | 1MG/0.5ML | INJECTABLE;INJECTION | Prescription | None | No | Yes |
PHYTONADIONE | PHYTONADIONE | 10MG/ML | INJECTABLE;INJECTION | Prescription | None | No | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
04/22/2022 | ORIG-1 | Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/214596Orig1s000ltr.pdf |
PHYTONADIONE
There are no Therapeutic Equivalents.